Homocysteine, folate and vitamin B12in neuropsychiatric diseases: review and treatment recommendations
Open accessThe DOI matches its Crossref record; 18 of the 18 references it cites were found in a registry or an index.
Abstract
In Europe, neuropsychiatric diseases currently make up approximately a third of the total burden of disease. In 2004, 27% of the overall population was affected by at least one of the most frequent neuropsychiatric diseases such as Alzheimer's dementia, Parkinson's disease, stroke or depression. The annual costs of care exceed those of cancer, cardiovascular conditions and diabetes. In order to delay the onset or course of neurodegenerative diseases, the available potential should be utilized. As well as improving quality of life of patients and relatives, this may reduce the great financial burden caused by neurodegenerative disorders. However, the availability of established drugs or therapeutic agents is very limited. This paper reviews the state of current knowledge as to how homocysteine metabolism is relevant for neurodegenerative and other neuropsychiatric diseases, with particular emphasis on the evidence for prophylactic and therapeutic strategies. In the European countries, many people do not take the recommended daily minimum amount of folate and vitamin B12. Deficiency of these vitamins and secondary changes in the concentrations of associated metabolites, such as methylmalonic acid and homocysteine, may contribute to the onset and progression of neuropsychiatric diseases. This paper reviews the evidence regarding whether substitution of folate and vitamin B12 is beneficial, for example, in cerebrovascular disease, dementia and depression.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Plasma Homocysteine as a Risk Factor for Dementia and Alzheimer's Disease
Seshadri, S., Beiser, A., Selhub, J., Jacques, P. F., Rosenberg, I. H., D'Agostino, R. B., Wilson, P. W. F., & Wolf, P. A. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa011613 · Cited by 3,237
Homocysteine and Risk of Ischemic Heart Disease and Stroke: A Meta-analysis
Homocysteine Studies Collaboration (2002) · JAMA · doi:10.1001/jama.288.16.2015 · Cited by 2,059
Vitamin Status and Intake as Primary Determinants of Homocysteinemia in an Elderly Population
Selhub, J. (1993) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1993.03510220049033 · Cited by 1,972 · cited 2×
“677C>T might be overridden or confounded by such factors [46-49].”
BackgroundHomocysteine Lowering with Folic Acid and B Vitamins in Vascular Disease
(2006) · New England Journal of Medicine · doi:10.1056/nejmoa060900 · Cited by 1,729
Hansson, O., Zetterberg, H., Buchhave, P., Londos, E., Blennow, K., & Minthon, L. (2006) · The Lancet Neurology · doi:10.1016/s1474-4422(06)70355-6 · Cited by 1,700
Homocysteine Lowering and Cardiovascular Events after Acute Myocardial Infarction
Bønaa, K. H., Njølstad, I., Ueland, P. M., Schirmer, H., Tverdal, A., Steigen, T., Wang, H., Nordrehaug, J. E., Arnesen, E., & Rasmussen, K. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa055227 · Cited by 1,442
Durga, J., van Boxtel, M. P., Schouten, E. G., Kok, F. J., Jolles, J., Katan, M. B., & Verhoef, P. (2007) · The Lancet · doi:10.1016/s0140-6736(07)60109-3 · Cited by 758
Enhancement of recovery from psychiatric illness by methylfolate
Godfrey, P. S. A., Toone, B. K., Bottiglien, T., Laundy, M., Reynolds, E. H., Carney, M. W. P., Flynn, T. G., & Chanarin, I. (1990) · The Lancet · doi:10.1016/0140-6736(90)91942-4 · Cited by 389
Coppen, A., & Bailey, J. (2000) · Journal of Affective Disorders · doi:10.1016/s0165-0327(00)00153-1 · Cited by 337
Kado, D. M., Karlamangla, A. S., Huang, M.-H., Troen, A., Rowe, J. W., Selhub, J., & Seeman, T. E. (2005) · The American Journal of Medicine · doi:10.1016/j.amjmed.2004.08.019 · Cited by 268
Sontag, E., Nunbhakdi-Craig, V., Sontag, J.-M., Diaz-Arrastia, R., Ogris, E., Dayal, S., Lentz, S. R., Arning, E., & Bottiglieri, T. (2007) · The Journal of Neuroscience · doi:10.1523/jneurosci.3316-06.2007 · Cited by 225
Low vitamin B-12 status and risk of cognitive decline in older adults
Clarke, R., Birks, J., Nexo, E., Ueland, P. M., Schneede, J., Scott, J., Molloy, A., & Evans, J. G. (2007) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/86.5.1384 · Cited by 203
S-adenosyl-l-methionine (SAMe) as antidepressant: meta-analysis of clinical studies
Bressa, G. M. (1994) · Acta Neurologica Scandinavica · doi:10.1111/j.1600-0404.1994.tb05403.x · Cited by 195
REVIEW: Vitamin transport and homeostasis in mammalian brain: focus on Vitamins B and E
Spector, R., & Johanson, C. E. (2007) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2007.04773.x · Cited by 175 · cited 1×
“Similarly, there exist active transport mechanisms for vitamin B6 and B12 [33,34].”
BackgroundHomocysteine and Cognitive Performance in the Framingham Offspring Study: Age Is Important
Elias, M. F., Sullivan, L. M., D'Agostino, R. B., Elias, P. K., Jacques, P. F., Selhub, J., Seshadri, S., Au, R., Beiser, A., & Wolf, P. A. (2005) · American Journal of Epidemiology · doi:10.1093/aje/kwi259 · Cited by 136
Homocysteine and cognitive function in the Sacramento Area Latino Study on Aging
Miller, J. W., Green, R., Ramos, M. I., Allen, L. H., Mungas, D. M., Jagust, W. J., & Haan, M. N. (2003) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/78.3.441 · Cited by 134 · cited 1×
“21 22 23 24 25 levels were suggested to explain 5 to 16% of the variance of cognitive function of healthy individuals [149,152].”
BackgroundSubsyndromal depression in the elderly: underdiagnosed and undertreated
VanItallie, T. B. (2005) · Metabolism · doi:10.1016/j.metabol.2005.01.012 · Cited by 115
Kendrick, T., Dunn, N., Robinson, S., Oestmann, A., Godfrey, K., Cooper, C., Inskip, H., & the Southampton Women’s Survey Study Group (2008) · Journal of Epidemiology and Community Health · doi:10.1136/jech.2007.069765 · Cited by 29 · cited 2×
“However, even in young individuals, this does not rule out a relevant role of folate in case of low folate levels [175] or when moderately decreased folate levels are combined with additional risk factors like the TT genotype of MTFR c.”
Background
Cited by
Intake and adequacy of the vegan diet. A systematic review of the evidence
Bakaloudi, D. R., Halloran, A., Rippin, H. L., Oikonomidou, A. C., Dardavesis, T. I., Williams, J., Wickramasinghe, K., Breda, J., & Chourdakis, M. (2021) · Clinical Nutrition · doi:10.1016/j.clnu.2020.11.035 · Cited by 466
Synaptic plasticity in depression: Molecular, cellular and functional correlates
Marsden, W. N. (2013) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2012.12.012 · Cited by 317
Damms-Machado, A., Friedrich, A., Kramer, K. M., Stingel, K., Meile, T., Küper, M. A., Königsrainer, A., & Bischoff, S. C. (2012) · Obesity Surgery · doi:10.1007/s11695-012-0609-0 · Cited by 229
Metadata
- Authors
- Stanger, O., Fowler, B., Piertzik, K., Huemer, M., Haschke-Becher, E., Semmler, A., Lorenzl, S., & Linnebank, M.
- Venue
- Expert Review of Neurotherapeutics
- Publisher
- Informa UK Limited
- Published
- 2009-09
- Volume
- 9
- Issue
- 9
- Pages
- 1393-1412
- ISSN
- 1473-7175 (ISSN-L)
- 1744-8360
- OpenAlex
- W2067117120
- Cited by
- 172
- References
- 18
- FWCI
- 7.40
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.